Exact Mass: 245.14471279999998
Exact Mass Matches: 245.14471279999998
Found 175 metabolites which its exact mass value is equals to given mass value 245.14471279999998,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
beta-Alanyl-L-arginine
This compound belongs to the family of Hybrid Peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta).
Alanylarginine
Alanylarginine is a dipeptide composed of alanine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Glutaminylvaline
C10H19N3O4 (245.13754939999998)
Glutaminylvaline is a dipeptide composed of glutamine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Asparaginylisoleucine
C10H19N3O4 (245.13754939999998)
Asparaginylisoleucine is a dipeptide composed of asparagine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Arginylalanine
Arginylalanine is a dipeptide composed of arginine and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Valylglutamine
C10H19N3O4 (245.13754939999998)
Valylglutamine is a dipeptide composed of valine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Isoleucyl-Asparagine
C10H19N3O4 (245.13754939999998)
Isoleucyl-Asparagine is a dipeptide composed of isoleucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Asparaginyl-Leucine
C10H19N3O4 (245.13754939999998)
Asparaginyl-Leucine is a dipeptide composed of asparagine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Leucyl-Asparagine
C10H19N3O4 (245.13754939999998)
Leucyl-Asparagine is a dipeptide composed of leucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Valyl-Gamma-glutamate
C10H19N3O4 (245.13754939999998)
Valyl-Gamma-glutamate is a dipeptide composed of valine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
S-3-oxodecanoyl cysteamine
S-3-oxodecanoyl cysteamine belongs to the family of Thioesters. These are compounds containing the ester derivative of thiocarboxylic acid,with the general structure R-S-CO-R (R,R=alkyl,aryl)
N-(3-(5,6,7,8-Tetrahydro-2-naphthyl)prop-2-enyl)acetohydroxamic acid
Ramifenazone
C14H19N3O (245.15280439999998)
Ramifenazone
C14H19N3O (245.15280439999998)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]acetamide
3-phenylacetoxynortropane|nortropan-3-yl phenylacetate|Phenylessigsaeure-nortropinester
Leu-Gly-Gly
C10H19N3O4 (245.13754939999998)
A tripeptide composed of one L-leucine and two glycine residues joined in sequence. CONFIDENCE standard compound; INTERNAL_ID 164
Arg-ala
A dipeptide formed from L-arginyl and L-alanine residues.
Asn-Ile
C10H19N3O4 (245.13754939999998)
A dipeptide obtained by formal condensation of the carboxy group of L-asparagine with the amino group of L-isoleucine.
Ile-Asn
C10H19N3O4 (245.13754939999998)
A dipeptide formed from L-isoleucine and L-asparagine residues.
Leu-asn
C10H19N3O4 (245.13754939999998)
A dipeptide composed of L-leucine and L-asparagine joined by a peptide linkage.
Val-Gln
C10H19N3O4 (245.13754939999998)
A dipeptide formed from L-valine and L-glutamine residues.
Val-gglu
C10H19N3O4 (245.13754939999998)
GGlu-Val
C10H19N3O4 (245.13754939999998)
Gly-gly-ile
C10H19N3O4 (245.13754939999998)
A tripeptide composed of glycine, glycine and L-isoleucine residues joined in sequence.
Gly-gly-leu
C10H19N3O4 (245.13754939999998)
A tripeptide composed of glycine, glycine and L-leucine residues joined in sequence.
Methyl (2S,3S)-3-[(tert-butyldimethylsilyl)oxy]azetidine-2-carbo
C11H23NO3Si (245.14471279999998)
5-TERT-BUTYL-2-(2-METHOXY-PHENYL)-2H-PYRAZOL-3-YLAMINE
C14H19N3O (245.15280439999998)
(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate
C10H19N3O4 (245.13754939999998)
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride
C11H21BClNO2 (245.13537860000002)
3-(tert-Butyl)-1-(3-methoxyphenyl)-1H-pyrazol-5-amine
C14H19N3O (245.15280439999998)
3-(TERT-BUTYL)-1-(4-METHOXYPHENYL)-1H-PYRAZOL-5-AMINE
C14H19N3O (245.15280439999998)
oxolamine
C14H19N3O (245.15280439999998)
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one
10-benzyl-5,8-dioxa-10-azadispiro[2.0.44.33]undecane
8-Benzyl-1,3,8-triazaspiro[4.5]decane-4-one
C14H19N3O (245.15280439999998)
1,2-Ethanediamine,N1-(2-furanylmethyl)-N2,N2-dimethyl-N1-2-pyridinyl-
C14H19N3O (245.15280439999998)
ETHYL 3-BENZYL-3-AZA-BICYCLO[3.1.0]HEXANE-6-CARBOXYLATE
6-(4-methylpiperazin-1-yl)-3,4-dihydro-2H-isoquinolin-1-one
C14H19N3O (245.15280439999998)
5-tert-butyl-1H-indole-2-carboxylic acid ethyl ester
Methyl spiro[cyclohexane-1,3-indoline]-4-carboxylate
(3E)-1-(2,6-dimethylphenyl)-3-(1-methylpyrrolidin-2-ylidene)urea
C14H19N3O (245.15280439999998)
1-Benzyl-4-cyclopropyl-3-pyrrolidinecarboxylic acid
1-(Hydroxycyclohexyl)-(4-methoxyphenyl)acetonitrile
(S,S,S)-2-Azabicyclo[3,3,0]octane-3-carboxylic acid benzylester hydrochloride
Tasimelteon
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CH - Melatonin receptor agonists C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
1-BENZYL-1,2,3,6-TETRAHYDROISONICOTINIC ACID ETHYL ESTER
[2-(1-adamantyloxy)propyl]amine hydrochloride
C13H24ClNO (245.15463239999997)
2-Amino-5-benzyl-3-methyl-5-propyl-3,5-dihydro-4H-imidazol-4-one
C14H19N3O (245.15280439999998)
2-Amino-5-butyl-3-methyl-5-phenyl-3,5-dihydro-4H-imidazol-4-one
C14H19N3O (245.15280439999998)
8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one
C14H19N3O (245.15280439999998)
diallyl n,n-diisopropylphosphoramidite
C12H24NO2P (245.15445739999998)
N-(3-(5,6,7,8-Tetrahydro-2-naphthyl)prop-2-enyl)acetohydroxamic acid
2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoic Acid
4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butanoic acid
(2S)-2-hydroxy-4-methyl-1-(1-methylindol-3-yl)pentan-3-one
N-(3,3,4,4-Tetradeutero-4-phenylbutyryl)piperidin-2-one
N-(2,2,3,3-Tetradeutero-4-phenylbutyryl)piperidin-2-one
N-(2,2,4,4-Tetradeutero-4-phenylbutyryl)piperidin-2-one
N-(2,2,3,3,4,4-Hexadeutero-4-phenylbutyryl)piperidin-2-one
Methyl 5-ethyl-3-methyl-2-phenyl-1-pyrroline-4-carboxylate (3,4-trans-4,5-cis)
Methyl trans-5-ethyl-ref.-4-methyl-2-phenyl-1-pyrroline-4-carboxylate
Gly-Gly-Ile zwitterion
C10H19N3O4 (245.13754939999998)
A tripeptide zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of Gly-Gly-Ile. Major microspecies at pH 7.3.
n-[2-(2,2-dimethylchromen-6-yl)ethyl]ethanimidic acid
(2r)-2-hydroxy-1-(1h-indol-3-yl)-4-methylhexan-3-one
(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate
{[(5z)-4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene]methyl}(2-methylpropyl)amine
C14H19N3O (245.15280439999998)
(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate
(2e)-2-methyl-3-[4-(4-methylidenecyclohexyl)furan-2-yl]prop-2-enimidic acid
n-[2-(4-methoxyphenyl)ethenyl]-n,3-dimethylbut-2-enamide
(2r)-2-hydroxy-1-(1h-indol-3-yl)-5-methylhexan-3-one
({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylpropyl)amine
C14H19N3O (245.15280439999998)
[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid
C10H19N3O4 (245.13754939999998)
(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid
C10H19N3O4 (245.13754939999998)
({4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)(2-methylpropyl)amine
C14H19N3O (245.15280439999998)